Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-22-006622

EVP R&D, Chief Medical Officer sold 11,983 shares at $24.76 ($296,650)

From the SEC's structured data for this filing

Trades in this filing

Hopkinson Craig C. · EVP R&D, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-23 Sale : show line 1 in the form −11,983 $24.76 $296,650 17,994 D
Open-market sales · 11,983 sh · avg $24.76 · $296,650
Loading xslF345X03/form4.xml…